Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
Quantitative Systems Pharmacology (QSP) and Pharmacometrics (PMX) have historically existed at the two ends of the model-informed drug development (MIDD) spectrum. The session "Mind the gap - successful bridging of QSP and PMX in drug development" at the 2024 American Conference of Pharmacometrics brought together QSP scientists and pharmacometricians with the aim to develop better understandings of how to bridge this gap. The current perspective is based on the concepts that were presented and the follow-up panel discussion.
Authors
- Georgi I. Kapitanov (ORCID: https://orcid.org/0000-0002-1173-542X)
- Cynthia J. Musante (ORCID: https://orcid.org/0000-0002-3003-0169)
- Mirjam N. Trame (ORCID: https://orcid.org/0000-0002-1030-4986)
- Anna Kondic
- Amita Joshi (ORCID: https://orcid.org/0009-0006-0017-2971)
- Jin Y. Jin (ORCID: https://orcid.org/0000-0002-3627-0323)
- Kapil Gadkar
- Justin Earp (ORCID: https://orcid.org/0009-0003-4784-6716)
- Blerta Shtylla
- Piet H. van der Graaf
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Center for Drug Evaluation and Research (US)
- Pfizer (United States) (US)
- Acentech (United States) (US)
- Certara (United States) (US)
- Centre for Human Drug Research (NL)
- Bristol-Myers Squibb (Sweden) (SE)
- Sunesis (United States) (US)
Publication Details
- Journal
- Clinical Pharmacology & Therapeutics
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1002/cpt.70191
- Citations
- 1
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 2.63